Gregory G. Reinholz - Concepedia

Author

Gregory G. Reinholz

Mayo Clinic

Also Known As

G G Reinholz, G. G. Reinholz, G.G. Reinholz, Gregory G. Reinholz, Gregory Reinholz

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic North Dakota State University University of Lübeck Mayo Clinic in Arizona

About

Gregory G. Reinholz is an author at Mayo Clinic specializing in medicine, orthopaedics, and regenerative medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	642
2	Engineering	4	4	152
3	Biomedical Engineering	4	4	152
4	Cell Biology	3	3	447
5	Health Sciences	2	2	405

Gregory G. Reinholz

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Gregory G. Reinholz, B. Getz, Larry Pederson, PubMed Cell ProliferationWhereas PamidronateOrthopaedic SurgeryOsteoporosisRegenerative Medicine	2000	366
Combined effects of insulin-like growth factor-1 and transforming growth factor-β1 on periosteal mesenchymal cells during chondrogenesis Tetsuya Fukumoto, Jens Sperling, A. K. Sanyal, Osteoarthritis and Cartilage	2002	241
Overexpression of a Nuclear Protein, TIEG, Mimics Transforming Growth Factor-β Action in Human Osteoblast Cells Theresa E. Hefferan, Gregory G. Reinholz, David J. Rickard, Journal of Biological Chemistry	2000	79
Tissue engineering of cartilage using poly-ɛ-caprolactone nanofiber scaffolds seeded in vivo with periosteal cells Michelle E. Casper, James S. Fitzsimmons, J.J. Stone, Osteoarthritis and Cartilage Tissue EngineeringEngineeringPoly-ɛ-caprolactone Nanofiber ScaffoldsBiomaterials DesignBiofabrication	2010	57
Poly‐ϵ‐caprolactone/gel hybrid scaffolds for cartilage tissue engineering Jan C. Schagemann, Hsi-Wei Chung, Eike Mrosek, Journal of Biomedical Materials Research Part A	2009	50
Porous tantalum and poly‐ε‐caprolactone biocomposites for osteochondral defect repair: Preliminary studies in rabbits Eike Mrosek, Jan C. Schagemann, Hsi‐Wei Chung, Journal of Orthopaedic Research®	2009	43
Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue Gregory G. Reinholz, Barbara J. Getz, Emily S. Sanders, Breast Cancer Research and Treatment Distinct MechanismsSclerostinBone Morphogenic ProteinBreast Cancer CellsBreast Cancer	2002	42
The effect of scaffold composition on the early structural characteristics of chondrocytes and expression of adhesion molecules Jan C. Schagemann, Haymo Kurz, Michelle E. Casper, Biomaterials Tissue EngineeringScaffoldsMechanobiologyEngineeringCell Adhesion	2010	39
A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites Monica M. Reinholz, Shawn Zinnen, Amylou C. Dueck, Bone Bone DiseasePromising ApproachTumor-induced Bone DiseasesBisphosphonate DerivativesMedicine	2010	39
Serum‐free media for periosteal chondrogenesis in vitro James S. Fitzsimmons, Arunik Sanyal, Carlos Gonzalez, Journal of Orthopaedic Research®	2003	33

Page 1